Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Grote toename aantal soa's wereldwijd
mei 2024 | Hepatitis, HIV, SOA, Venereologie